Leerink Partnrs Has Pessimistic View of Vaxcyte Q1 Earnings
Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) – Investment analysts at Leerink Partnrs lowered their Q1 2025 earnings per share (EPS) estimates for shares of Vaxcyte in a note issued to investors on Tuesday, April 1st. Leerink Partnrs analyst D. Risinger now expects that the company will earn ($1.07) per share for the quarter, down from […]
Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) – Investment analysts at Leerink Partnrs lowered their Q1 2025 earnings per share (EPS) estimates for shares of Vaxcyte in a note issued to investors on Tuesday, April 1st. Leerink Partnrs analyst D. Risinger now expects that the company will earn ($1.07) per share for the quarter, down from […]
